Personalize this feed and join discussions.Create account
See more ›
DV$DVLT#1

A $DVLT scenario analysis of the path to $1: the $100M $QEST purchase order, the $200M FY2026 target, cash conversion, repeatability, dilution, and the Nasdaq compliance clock.

Trending on GoGlides
DV$DVLT#2

Datavault AI says it received a $100M $QEST purchase order and intends to recognize it in Q3. I built the bridge from that headline to GAAP revenue, cash, and per-share proof.

Trending on GoGlides
DV$DVLT#3

DataMEDS's all-stock acquisition of Helomics makes the $DVLT healthcare connection more tangible, but the transaction still leaves the important questions unanswered: what was issued, what closes, and when does any of this become collected cash?

Trending on GoGlides

Top discussions

See more ›
$RUMRUM Group: Deep-Dive Initiation of Coverage12   💬 Join the discussion$BIG10Lake Street BIG10 2026: Conference Intelligence Deep-Dive: What the Roster, Research Network, Banking Record, and DVLT Relationship Actually Show12   💬 Join the discussion$UNHUnitedHealth Group: Deep-Dive Initiation of Coverage12   💬 Join the discussion

GoGlides Research· $DVLT · Sep 16, 2026

GoGlides research

$DVLT Path to $1: What Has to Happen Before the Math Works

A $DVLT scenario analysis of the path to $1: the $100M $QEST purchase order, the $200M FY2026 target, cash conversion, repeatability, dilution, and the Nasdaq compliance clock.

Why this mattersA $DVLT scenario analysis of the path to $1: the $100M $QEST purchase order, the $200M FY2026 target, cash conversion, repeatability, dilution, and the Nasdaq compliance clock.

Source-backed research · company filings · primary evidence

GoGlides Research· $DVLT · Sep 15, 2026

GoGlides research

The $DVLT Ecosystem Is Growing. Why Is the Stock Still Falling?

DataMEDS's all-stock acquisition of Helomics makes the $DVLT healthcare connection more tangible, but the transaction still leaves the important questions unanswered: what was issued, what closes, and when does any of this become collected cash?

Source-backed research · company filings · primary evidence

GoGlides Research· $RUM · Sep 14, 2026

GoGlides research

RUM Group: Deep-Dive Initiation of Coverage

A filing-led initiation covering Rumble Video, Quake AI, the Northern Data acquisition, the $13.7 billion GPU agreement, Tether dependencies, liquidity, governance and layered dilution.

Source-backed research · company filings · primary evidence

GoGlides Research· $BIG10 · Sep 14, 2026

GoGlides research

Lake Street BIG10 2026: Conference Intelligence Deep-Dive: What the Roster, Research Network, Banking Record, and DVLT Relationship Actually Show

A standalone investigation of Lake Street Capital Markets' 2026 BIG10 conference, its 126-company roster, the overlap between research and banking relationships, the evidence from post-BIG9 financings, and what Datavault AI's participation does and does not signal.

Source-backed research · company filings · primary evidence

GoGlides Research· $UNH · Sep 11, 2026

GoGlides research

UnitedHealth Group: Deep-Dive Initiation of Coverage

A filing-led initiation covering UnitedHealthcare, Optum, 2026 earnings recovery, Medicare Advantage repricing, medical-cost reserves, parent liquidity, regulatory exposure, acquisition commitments and scenario valuation.

Source-backed research · company filings · primary evidence

GoGlides Research· $OPEN · Sep 10, 2026

GoGlides research

Opendoor Technologies: Deep-Dive Initiation of Coverage

A filing-led initiation covering Opendoor's home-purchase engine, Q2 2026 earnings, the September guidance reset, inventory economics, liquidity, August financing, dilution, adjacent services and scenario valuation.

Source-backed research · company filings · primary evidence

GoGlides Research· $INTC · Sep 9, 2026

GoGlides research

Intel Corporation: September 2026 Thesis Delta

A standalone, filing-led Intel thesis update testing stronger 18A, 14A and EMIB-T evidence against higher capital needs, unchanged external Foundry economics, dilution and the valuation now embedded in the shares.

Source-backed research · company filings · primary evidence